Lung Cancer Clinical Trials in Ohio

Showing 361-363 of 363 trials

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

NCT00014547

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BBR 3464 in treating patients who have metastatic small cell lung cancer that has not responded to previous treatment.

Lung Cancer

TheradexStarted Nov 2000

Hoover, Alabama, United States • Fayetteville, Arkansas, United States • Berkeley, California, United States +15 more locations

UNKNOWNPHASE1/PHASE232 miles

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NCT00082472

This study is intended to show whether inhaled chemotherapy can be added to a standard IV chemotherapy regime, to investigate the additional toxicities and to show initial evidence of efficacy of the combination.

NSCLC

Zivena30 participantsStarted Jan 2004

New Haven, Connecticut, United States • Las Vegas, Nevada, United States • Las Vegas, Nevada, United States +3 more locations

PreviousPage 19 of 19

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Lung Cancer Trials in Other Cities

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Other Conditions in Ohio